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Abstract
Introduction Delayed cerebral ischemia (DCI) after aneurys-
mal subarachnoid hemorrhage (aSAH) can be reversible or
progress to cerebral infarction. In patients with a deterioration
clinically diagnosed as DCI, we investigated whether CT per-
fusion (CTP) can distinguish between reversible ischemia and
ischemia progressing to cerebral infarction.
Methods From a prospectively collected series of aSAH pa-
tients, we included those with DCI, CTP on the day of clinical
deterioration, and follow-up imaging. In qualitative CTP anal-
yses (visual assessment), we calculated positive and negative
predictive value (PPV and NPV) with 95 % confidence inter-
vals (95%CI) of a perfusion deficit for infarction on follow-up
imaging. In quantitative analyses, we compared perfusion
values of the least perfused brain tissue between patients with
and without infarction by using receiver-operator characteristic
curves and calculated a threshold value with PPVand NPV for
the perfusion parameter with the highest area under the curve.
Results In qualitative analyses of 33 included patients, 15 of
17 patients (88 %) with and 6 of 16 patients (38 %) without
infarction on follow-up imaging had a perfusion deficit during
clinical deterioration (p=0.002). Presence of a perfusion def-
icit had a PPVof 71 % (95%CI: 48–89 %) and NPVof 83 %
(95%CI: 52–98 %) for infarction on follow-up. Quantitative
analyses showed that an absolute minimal cerebral blood flow
(CBF) threshold of 17.7 mL/100 g/min had a PPV of 63 %
(95%CI: 41–81 %) and a NPVof 78 % (95%CI: 40–97 %) for
infarction.
Conclusions CTP may differ between patients with DCI who
develop infarction and those who do not. For this purpose,
qualitative evaluation may perform marginally better than
quantitative evaluation.
Keywords CT perfusion . Delayed cerebral ischemia .
Subarachnoid hemorrhage
Introduction
Delayed cerebral ischemia (DCI) is a severe complication of
aneurysmal subarachnoid hemorrhage (aSAH). DCI affects
approximately 20–30 % of patients who survive the initial
hemorrhage and usually occurs between 4 and 14 days after
the hemorrhage [1, 2]. Clinical deterioration from DCI can
present as a new focal neurologic impairment, a decrease in
the level of consciousness, or both [3]. DCI can be reversible
or progress to cerebral infarction, which increases the risk of
poor functional outcome [4–6]. DCI is mainly a clinical diag-
nosis at onset based on exclusion of other causes of the dete-
rioration and confirmed by follow-up imaging showing cere-
bral infarction, but recent studies have shown that CT perfu-
sion (CTP) can be helpful to detect DCI at the time of clinical
deterioration [7]. However, it remains unknown if patients
with reversible ischemia can be distinguished from patients
with ischemia progressing to cerebral infarction. Such differ-
entiation would be useful for clinical trials testing the efficacy
of interventions to prevent cerebral infarction. DCI can be
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assessed with CTP in different ways: qualitatively (with visual
detection of a perfusion deficit) and with quantitative thresh-
olds (both absolute and relative).
The purpose of this study was to investigate whether CTP
can distinguish between reversible ischemia and ischemia
progressing to cerebral infarction.
Methods
Design
This study was approved by the institutional review board.
Patients were selected from a prospectively collected series
of consecutive aSAH patients admitted to our hospital be-
tween August 2007 and November 2010. In our hospital, all
patients with aSAH routinely undergo multimodal CT,
consisting of non-contrast CT (NCCT), CTP, and CT-
angiography (CTA), on admission and at the time of clinical
deterioration after aSAH. Inclusion criteria for this study were
(1) 18 years of age or older, (2) clinical deterioration due to
DCI within 21 days after aSAH, (3) NCCT and CTP imaging
at the onset of clinical deterioration, and (4) follow-up imag-
ing (CT or MRI) at least 3 days after onset of clinical deteri-
oration. Exclusion criteria were pregnancy, impaired renal
function (creatinine >200 μmol/L) or other contraindications
for contrast administration, and CTP scans with extensive
movement artifacts. In our institution, none of the SAH pa-
tients are treated with endovascular rescue therapy.
DCI
Clinical deterioration due to DCI was defined as a clinical
deterioration (new focal deficit or decrease in Glasgow Coma
Scale of at least two points on the total score or one of its
individual components or both) lasting 1 h or longer with no
evidence for rebleeding or hydrocephalus on CT and no other
medical causes, such as cardiovascular or pulmonary compli-
cations, infections, or metabolic disturbances [3].
Cerebral infarction due to DCI was defined as a new in-
farction on follow-up CT or MRI that was not present on
earlier imaging and could not be attributed to other causes
such as aneurysm treatment, ventricular catheter placement,
or intraparenchymal hematoma [3].
CTP imaging
All imaging studies were performed on a 16-, 64-, or 128-
multidetector CT scanner (Philips Mx8000 IDT 16, Philips
Brilliance 16P, Philips Brilliance 64, Philips Brilliance iCT;
Best, the Netherlands). For the CTP scan, 40 ml of non-ionic
contrast agent (lopromide, Ultravist, 300 mg iodine/ml,
Schering, Berlin, Germany) was injected into the cubital vein
(18-gauge needle) at a rate of 5 ml/s followed by a 40ml saline
flush at a rate of 5 ml/s using a dual power injector (Stellant
Dual CT injector, Medrad Europe BV, Beek, the Netherlands).
The following parameters were used: 16 slice, 90 kVp,
150 mAs, 8×3 mm collimation; 64 slice, 80 kVp, 150 mAs,
64×0.625 mm collimation; 128 slice, 80 kVp, 150 mAs,
128×0.625 mm collimation. All scanners used a 512×512
matrix, a field of view ranging from 160 to 220 mm, UB filter
and standard resolution and acquired one image per 2 s during
60 s.
CTP post-processing
CT perfusion maps were generated using an open source soft-
ware package (Perfusion Mismatch Analyzer, PMA version
4.0.4.4, ASIST Japan). The optimal arterial input function
(AIF) and venous output function (VOF) were automatically
selected by the software and corrected manually if necessary.
Patient movement was corrected with Elastix, and for noise
reduction, a filter using the time-intensity profile similarity to
reduce noise in the spatial domain was applied [8, 9]. Quanti-
tative cerebral perfusion values were calculated using block-
circulant singular value decomposition (bSVD), which is de-
scribed as a tracer delay-insensitive algorithm [10]. CTPmaps
were created for cerebral blood flow (CBF), cerebral blood
volume (CBV), mean transit time (MTT), and time to peak
(TTP).
An in-house software tool was developed using Mevislab
(®MevisLab, software for medical image processing and vi-
sualization; http://www.mevislab.de) for visualization of the
perfusion maps and to extract statistics from regions of interest
(ROIs) that were manually placed on the perfusion maps.
CTP evaluation
CT perfusion maps were evaluated qualitatively (visual as-
sessment) and quantitatively. Qualitative evaluation was done
by one observer (JWD, 8-year experience with CTP in DCI)
who was blinded for follow-up imaging and the final diagno-
sis but with knowledge of the patient’s clinical condition at the
time of imaging (GCS-scores and focal deficit if applicable).
For every patient, the four CTP maps were displayed together
with the NCCT. Positive findings were hypoperfused areas
(lower CBF or CBV or higher MTT or TTP), which were
not localized in the neurosurgical trajectory, directly surround-
ing an intracerebral hematoma, or caused by an endovascular
intervention.
For quantitative analyses, we investigated the least per-
fused region of the brain by selecting the lowest CBF and
CBV value and the highest MTT and TTP value. The least
perfused region was selected from standard ROIs and perfu-
sion deficits (if applicable):
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1. Standard ROIs were drawn in the cortical flow territories
of the anterior cerebral artery (ACA), middle cerebral ar-
tery (MCA), and posterior cerebral artery (PCA) and in
the basal ganglia (Fig. 1). Because perfusion in unaffected
white matter can be lower than perfusion in a perfusion
deficit in gray matter, we did not include white matter
regions in the standard ROIs.
2. Perfusion deficits. In all patients with a visible perfusion
deficit on CTP during clinical deterioration, the deficit
was manually delineated. Delineation was done blinded
for the results of follow-up imaging.
For relative perfusion values, the least perfused ROI was
compared to the contralateral ROI. Subsequently, for CBF and
CBV minimal ratios of cerebral perfusion values were calcu-
lated and for MTT and TTP maximal differences of perfusion
values were calculated.
Analyses
For the qualitative analyses, we calculated positive and nega-
tive predictive values (PPV and NPV) with corresponding
95 % confidence intervals (95 % CI) of presence of perfusion
deficits for infarction on follow-up. Subsequently, we deter-
mined the proportion of patients with a perfusion deficit on
CTP during clinical deterioration for patients with and without
an infarction on follow-up imaging. Differences between
groups were analyzed using the chi-square test.
For the quantitative analyses, we constructed a receiver-
operator characteristic (ROC) curve for the distinction be-
tween patients with and without an infarction on follow-up
imaging for all parameters and calculated the area under the
curve (AUC). Of all perfusion parameters, the parameter with
the highest AUC was selected and, subsequently, PPV and
NPV (with 95 % CI) for the threshold value with the optimal
diagnostic cutoff point were calculated.
Results
We included 33 patients with clinical deterioration due to DCI,
of which 17 patients had an infarction on follow-up imaging
(Table 1). Four patients were scanned on a 16-multidetector
CTscanner, 18 patients on a 64-multidetector CTscanner, and
11 patients on a 128-multidetector CT scanner.
Qualitative analyses
A perfusion deficit was seen on CTP during clinical deterio-
ration in 15 of 17 patients (88 %) with a final infarction on
follow-up imaging compared to 6 of 16 patients (38 %) with-
out a final infarction (p=0.002) (Table 1). The PPV for the
development of an infarction was 71 % (95%CI: 48–89 %)
and the NPV was 83 % (95%CI: 52–98 %).
Quantitative analyses
For the least perfused region of the brain, median perfusion
values (with interquartile ranges (IQR)) for DCI patients with
and without an infarction on follow-up are presented in
Table 2. A trend towards lower CBF and CBV and longer
MTT and TTP was seen in patients with infarction com-
pared to patients without an infarction on follow-up imag-
ing. The AUC of the ROC curve for absolute CBF was
0.65, for CBV 0.58, for MTT 0.60, and for TTP 0.50. For
the relative perfusion values, the AUCs were for CBF 0.52,
CBV 0.47, MTT 0.57, and for TTP 0.52. Since the abso-
lute CBF had the highest AUC, this parameter was selected
for further analysis. An absolute CBF threshold of
17.7 mL/100 g/min showed a PPV of 63 % (95%CI: 41–
81 %) and a NPV of 78 % (95%CI: 40–97 %).
Discussion
The results of our study show that in patients with clinical
deterioration due to DCI, qualitative CTP assessment predicts
better an infarction on follow-up than quantitative assessment;
however, the predictive values of perfusion deficits are only
moderate. Patients with a visually assessed perfusion deficit at
the time of clinical deterioration more often have an infarction
on follow-up imaging than such patients without a perfusion
deficit.
The distinction between reversible ischemia and ischemia
progressing to infarction in patients with clinical deterioration
due to DCI has been studied only once before in a subgroup
analysis of a study investigating the value of CTP in
predicting outcome after aSAH [11]. In that study, perfusion
scans were visually assessed and additionally quantitative
measurements were performed in standard ROIs. In contrast
to our results, that study found no significant difference in the
Fig. 1 Standard ROIs in the cortical flow territories of the anterior
cerebral artery, middle cerebral artery, and posterior cerebral artery and
in the basal ganglia
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qualitative analyses of patients with and without an infarction,
although a trend was seen to a higher proportion of visually
assessed CTP deficits in DCI patients with infarction on
follow-up compared to DCI patients without infarction
[11]. In that study, 15 patients with infarction and 33 pa-
tients without infarction were included. Different software
packages were used in both studies to generate the perfu-
sion maps, which might explain the different results that
were found. Therefore, standardized methods for measuring
perfusion with CTP after SAH are needed [7]. In the quan-
titative analyses of that study also no significant differences
were found between DCI patients with and without an in-
farction. Our study design for the quantitative analyses dif-
fers essentially from the previous study. We measured per-
fusion in the area with the lowest perfusion in each patient
in a visually delineated perfusion deficit or in the absence
of a perfusion deficit in the lowest standard ROI. In con-
trast, the previous study measured perfusion either in







Women (n, %) 12 (71 %) 14 (88 %)
Age (mean, range) 52 (29–67) 58 (28–81)
Admission WFNS score (%)
I 7 (41 %) 4 (25 %)
II 5 (29 %) 5 (31 %)
III 2 (12 %) 1 (6 %)
IV 1 (6 %) 4 (25 %)
V 2 (12 %) 2 (13 %)
Aneurysm location (%)
Acom, ACA 8 (47 %) 7 (44 %)
Pcom 3 (18 %) 5 (31 %)
BA 3 (18 %) 2 (13 %)
ICA 3 (18 %) 2 (13 %)
Treatment (%)
Coil 10 (59 %) 9 (56 %)
Clip 6 (35 %) 6 (38 %)
None 0 (0 %) 1 (6 %)
Both 1 (6 %) 0 (0 %)
Hypertension induction as treatment for DCI (%) 5 (29 %) 4 (25 %)
Perfusion deficit visible on CTP during clinical deterioration (%) 15 (88 %) 6 (38 %)
Clinical presentation at time of clinical deterioration (%)
WFNS score
I 0 (0 %) 0 (0 %)
II 1 (6 %) 1 (6 %)
III 1 (6 %) 1 (6 %)
IV 6 (35 %) 3 (19 %)
V 2 (12 %) 5 (31 %)
Focal deficit 6 (35 %) 5 (31 %)
Unknown 1 (6 %) 1 (6 %)
Mean CTP value (with SD) per patient (standard ROIs and perfusion deficits)
CBF (mL/100 g/min) 25.29 (9.76) 30.38 (12.43)
CBV (mL/100 g) 2.79 (0.98) 3.21 (1.15)
MTT (s) 14.43 (1.97) 13.88 (1.07)
TTP (s) 14.20 (3.04) 14.09 (2.09)
DCI delayed cerebral ischemia, WFNS World Federation of Neurosurgeons, Acom anterior communicating
artery, ACA anterior cerebral artery, Pcom posterior communicating artery, BA basilar artery, ICA internal carotid
artery, CTP CT perfusion, SD standard deviation, ROIs regions of interest, CBF cerebral blood flow, CBV
cerebral blood volume, MTT mean transit time, TTP time to peak
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standard ROIs located within a perfusion deficit or used, in
those patients without a perfusion deficit, the mean value of
all standard ROIs instead of the ROI with lowest perfusion
[11]. In our opinion, the comparison of the measurements
in a perfusion deficit to the lowest values in patients with-
out deficits is more realistic if quantitative differences be-
tween the two groups are being evaluated.
The absolute perfusion values found in our study are
lower compared to perfusion values found in other stud-
ies in DCI patients [12, 13]. This can be explained by
the fact that we measured perfusion in perfusion deficits
and used the least perfused region, whereas in other
studies the mean value of standard ROIs was used. In
addition, quantitative perfusion values may differ due to
differences in CTP algorithms [14]. Because absolute
perfusion values are known to vary and may be influ-
enced by user-dependent post-processing steps [14, 15],
we also evaluated relative CTP measurements and found
comparable results to the absolute CTP measurements.
In patients with ischemic stroke, a prediction map based on
quantitative thresholds is used to distinguish between revers-
ible and irreversible ischemic tissue [16]. Since we found low-
er predictive values for the quantitative thresholds compared
to the qualitative assessment in this study, the development of
a prediction map in DCI patients seems less useful than visual
assessment.
Although the PPV and NPV of the visual assessment
with CTP found in this study were not overwhelming,
the visual assessment of CTP could be useful in clinical
practice to give an indication of the chance of develop-
ing an infarction due to DCI. However, the predictive
values of the visual assessment of CTP to distinguish
between DCI patients with and without infarction need
to be validated in a prospective study. In addition, its
value for predicting outcome needs to be evaluated.
Other techniques like diffusion-weighted MRI may be
more suited to detect irreversible ischemia in an early stage
[17]. However, the use of MRI is often challenging in SAH
patients because of incompatibility of monitoring equipment
with the MR suite. In addition, in many hospitals, MRI is still
not available around the clock. Several technical improve-
ments for CTP imaging are currently being investigated
[18–20]. This may make more accurate estimation of irrevers-
ible ischemia possible in the future.
Some limitations need to be addressed. Although the
definition for DCI used in our study is widely accepted
[3], the diagnosis of DCI is based on excluding other
causes of clinical deterioration. Since there are many
factors influencing the occurrence of clinical deteriora-
tion after aSAH, there may still be some misclassifica-
tion, which may influence predictive values. Another
potential limitation is that the qualitative assessment of
the CTP scans was done by a single observer. In a
previous study, lower test characteristics were found
for a less experienced observer compared to an experi-
enced observer; however this was based on only two
observers [21]. In stroke studies, good reproducibility
was found for visual assessment of CTP images [22].
Finally, although the percentage of patients receiving
induced hypertension was similar in patients with and
without an infarct on follow-up, the change in blood
pressure and thereby cerebral blood flow may not have
been equal. This may have introduced some bias. On
the other hand, there are no data available in the liter-
ature on the effect of induced hypertension on the de-
velopment of infarction.
To conclude, CTP may differ between patients with
DCI who develop infarction and those who do not, but
before these findings can be implemented in clinical prac-
tice, they should be confirmed in different patient
Table 2 Lowest perfusion values
CTP parameter Infarction at follow-up (n=17) No infarction at follow-up (n=16)
Absolute values (median (IQR))
CBF (mL/100 g/min) 11.66 (8.34–16.32) 16.08 (8.92–23.57)
CBV (mL/100 g) 1.66 (1.07–2.14) 1.78 (1.23–2.44)
MTT (s) 21.72 (16.76–26.54) 18.83 (15.65–23.05)
TTP (s) 19.18 (14.86–23.76) 18.24 (16.29–21.94)
Relative values (median (IQR))
CBF ratio 0.53 (0.42–0.60) 0.56 (0.36–0.62)
CBV ratio 0.57 (0.53–0.65) 0.59 (0.45–0.65)
MTT difference (s) 7.62 (2.96–12.10) 4.68 (2.29–9.44)
TTP difference (s) 3.77 (2.16–8.92) 4.46 (1.77–8.01)
Lowest perfusion values: lowest value and ratio in CBF and CBVand highest value and difference in MTT and
TTP, measured in standard ROIs in gray matter and basal ganglia or perfusion deficits (if applicable)
CTP CT perfusion, n number, IQR interquartile range (25–75 %), CBF cerebral blood flow, CBV cerebral blood
volume,MTT mean transit time, TTP time to peak.
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populations in different centers. To differentiate between
the two groups, qualitative analysis may perform margin-
ally better than quantitative analysis.
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